Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):325–329. doi: 10.1128/cdli.2.3.325-329.1995

Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus.

M Ohlin 1, B Plachter 1, V A Sundqvist 1, P G Steenbakkers 1, J M Middeldorp 1, C A Borrebaeck 1
PMCID: PMC170154  PMID: 7545078

Abstract

The lower matrix protein (pp65) is a major product of many laboratory strains of cytomegalovirus (CMV). It is thus an integral part of many CMV serological assays based on native antigen. Recombinant fragments of pp65 have previously been investigated for their usefulness in more-defined assays. The latter antigens have, however, failed to develop a positive response with serum samples derived from a substantial number of infected individuals. Here we show that the human humoral immune response to CMV pp65 is highly diverse and recognizes at least seven distinct but in some cases partly overlapping epitopes. Most of these epitopes could not be mimicked by any of the investigated recombinant or synthetic antigens. Furthermore, when we investigated the ability of human CMV-seropositive serum samples to block the reactivity of pp65-specific antibodies recognizing five different epitopes within pp65, it was evident that several sera did not contain significant levels of antibodies against any of these or overlapping structures. It was thus concluded that the antibody response against CMV pp65 is weak in some CMV-infected individuals, making this antigen unsuitable for use alone in serological screening systems for CMV infection.

Full Text

The Full Text of this article is available as a PDF (211.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander H., Harpprecht J., Podzuweit H. G., Rautenberg P., Müller-Ruchholtz W. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus. Hum Antibodies Hybridomas. 1994;5(1-2):81–90. [PubMed] [Google Scholar]
  2. Grefte J. M., van der Gun B. T., Schmolke S., van der Giessen M., van Son W. J., Plachter B., Jahn G., The T. H. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol. 1992 Nov;73(Pt 11):2923–2932. doi: 10.1099/0022-1317-73-11-2923. [DOI] [PubMed] [Google Scholar]
  3. Hayes K., Alford C., Britt W. Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. J Infect Dis. 1987 Oct;156(4):615–621. doi: 10.1093/infdis/156.4.615. [DOI] [PubMed] [Google Scholar]
  4. Irmiere A., Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology. 1983 Oct 15;130(1):118–133. doi: 10.1016/0042-6822(83)90122-8. [DOI] [PubMed] [Google Scholar]
  5. Jahn G., Scholl B. C., Traupe B., Fleckenstein B. The two major structural phosphoproteins (pp65 and pp150) of human cytomegalovirus and their antigenic properties. J Gen Virol. 1987 May;68(Pt 5):1327–1337. doi: 10.1099/0022-1317-68-5-1327. [DOI] [PubMed] [Google Scholar]
  6. Landini M. P., Guan M. X., Jahn G., Lindenmaier W., Mach M., Ripalti A., Necker A., Lazzarotto T., Plachter B. Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol. 1990 Jun;28(6):1375–1379. doi: 10.1128/jcm.28.6.1375-1379.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Landini M. P., Re M. C., Mirolo G., Baldassarri B., La Placa M. Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol. 1985 Dec;17(4):303–311. doi: 10.1002/jmv.1890170403. [DOI] [PubMed] [Google Scholar]
  8. Lindenmaier W., Necker A., Krause S., Bonewald R., Collins J. Cloning and characterization of major antigenic determinants of human cytomegalovirus Ad169 seen by the human immune system. Arch Virol. 1990;113(1-2):1–16. doi: 10.1007/BF01318349. [DOI] [PubMed] [Google Scholar]
  9. Ljungman P., Wahren B., Sundqvist V. A. Lymphocyte proliferation and IgG production with herpesvirus antigens in solid phase. J Virol Methods. 1985 Dec;12(3-4):199–208. doi: 10.1016/0166-0934(85)90130-2. [DOI] [PubMed] [Google Scholar]
  10. Middeldorp J. M., Jongsma J., The T. H. Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens. J Clin Microbiol. 1986 Sep;24(3):405–413. doi: 10.1128/jcm.24.3.405-413.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ohlin M., Sundqvist V. A., Gilljam G., Rudén U., Gombert F. O., Wahren B., Borrebaeck C. A. Characterization of human monoclonal antibodies directed against the pp65-kD matrix antigen of human cytomegalovirus. Clin Exp Immunol. 1991 Jun;84(3):508–514. [PMC free article] [PubMed] [Google Scholar]
  12. Pande H., Campo K., Tanamachi B., Zaia J. A. Human cytomegalovirus strain Towne pp65 gene: nucleotide sequence and expression in Escherichia coli. Virology. 1991 May;182(1):220–228. doi: 10.1016/0042-6822(91)90665-x. [DOI] [PubMed] [Google Scholar]
  13. Plachter B., Klages S., Hagelmann S., Britt W., Landini M. P., Jahn G. Procaryotic expression of phosphorylated tegument protein pp65 of human cytomegalovirus and application of recombinant peptides for immunoblot analyses. J Clin Microbiol. 1990 Jun;28(6):1229–1235. doi: 10.1128/jcm.28.6.1229-1235.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Plachter B., Wieczorek L., Scholl B. C., Ziegelmaier R., Jahn G. Detection of cytomegalovirus antibodies by an enzyme-linked immunosorbent assay using recombinant polypeptides of the large phosphorylated tegument protein pp150. J Clin Microbiol. 1992 Jan;30(1):201–206. doi: 10.1128/jcm.30.1.201-206.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Revello M. G., Percivalle E., Di Matteo A., Morini F., Gerna G. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J Gen Virol. 1992 Feb;73(Pt 2):437–442. doi: 10.1099/0022-1317-73-2-437. [DOI] [PubMed] [Google Scholar]
  16. Rüger B., Klages S., Walla B., Albrecht J., Fleckenstein B., Tomlinson P., Barrell B. Primary structure and transcription of the genes coding for the two virion phosphoproteins pp65 and pp71 of human cytomegalovirus. J Virol. 1987 Feb;61(2):446–453. doi: 10.1128/jvi.61.2.446-453.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shen C. Y., Chang S. F., Yang S. L., Yeh T. S., Huang E. S., Wu C. W. Humoral immune responses and cytomegalovirus excretion in children with asymptomatic infection. J Med Virol. 1994 Sep;44(1):37–42. doi: 10.1002/jmv.1890440108. [DOI] [PubMed] [Google Scholar]
  18. Steenbakkers P. G., Van Wezenbeek P. M., van Zanten J., The T. H. Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells. Hum Antibodies Hybridomas. 1993 Oct;4(4):166–173. [PubMed] [Google Scholar]
  19. Tomiyama T., Matsumoto Y., Sugano T., Fujinaga S., Masuho Y. Preparation of human monoclonal antibodies against a cytomegalovirus glycoprotein complex of 130 and 55 kDa. J Immunol Methods. 1990 Aug 7;131(2):249–255. doi: 10.1016/0022-1759(90)90196-3. [DOI] [PubMed] [Google Scholar]
  20. Vornhagen R., Plachter B., Hinderer W., The T. H., Van Zanten J., Matter L., Schmidt C. A., Sonneborn H. H., Jahn G. Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol. 1994 Apr;32(4):981–986. doi: 10.1128/jcm.32.4.981-986.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Zaia J. A., Forman S. J., Ting Y. P., Vanderwal-Urbina E., Blume K. G. Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients. J Infect Dis. 1986 Apr;153(4):780–787. doi: 10.1093/infdis/153.4.780. [DOI] [PubMed] [Google Scholar]
  22. van Zanten J., van der Giessen M., van Son W. J., The T. H. Antibody responses to human cytomegalovirus-specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection. J Med Virol. 1993 Jan;39(1):80–87. doi: 10.1002/jmv.1890390115. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES